Protocols for Monitoring and Managing Long-Term Complications of Bispecific Therapy in Mutlplie Myeloma
Panelists discuss how comprehensive long-term monitoring protocols for patients who have received bispecific therapy typically involve regular follow-ups, standardized testing schedules, and clear communication channels between academic centers and community practices to manage potential complications and adverse events.
Video content above is prompted by the following:
- What protocols and processes do you have in place to continue monitoring and managing potential long-term complications or adverse events associated bispecific therapy (risk of infections, etc)?
Recent Videos
